日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

Musashi-2 (MSI2) 调节表皮生长因子受体 (EGFR) 的表达以及 EGFR 突变型非小细胞肺癌 (NSCLC) 对 EGFR 抑制剂的反应

Petr Makhov #,Igor Bychkov #,Bulat Faezov,Alexander Deneka,Alexander Kudinov,Emmanuelle Nicolas,Rohan Brebion,Eleanor Avril,Kathy Q Cai,Leonid V Kharin,Mark Voloshin,Elena Frantsiyants,Nikolay Karnaukhov,Oleg I Kit,Iuliia Topchu,Rushaniya Fazliyeva,Anna S Nikonova,Ilya G Serebriiskii,Hossein Borghaei,Martin Edelman,Essel Dulaimi,Erica A Golemis,Yanis Boumber

Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial

塞来昔布联合新辅助化疗治疗乳腺癌可能会因 COX-2 表达和 ER 状态不同而导致疗效恶化:REMAGUS02 试验的探索性分析

Anne-Sophie Hamy, Sandrine Tury, Xiaofei Wang, Junheng Gao, Jean-Yves Pierga, Sylvie Giacchetti, Etienne Brain, Barbara Pistilli, Michel Marty, Marc Espié, Gabriel Benchimol, Enora Laas, Marick Laé, Bernard Asselain, Brice Aouchiche, Martin Edelman, Fabien Reyal